Trademark Attorney / Law Firm
James M. DeZelar – Trademark Portfolio
James M. DeZelar specializes in Class 42 (Computer & Scientific) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 7 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 5 other Nice Classification classes. Filing activity spans from 1993 to 1995. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
James M. DeZelar's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademark applications has James M. DeZelar filed?
James M. DeZelar has filed 7 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does James M. DeZelar specialize in?
James M. DeZelar has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products), Class 37 (Building & Construction), Class 39 (Transportation & Storage). Class 42 covers scientific and technological services; industrial analysis and research services.
How long has James M. DeZelar been filing trademarks?
James M. DeZelar's trademark filing history with the USPTO spans from 1993 to 1995, covering 2 years of trademark practice. During this period, James M. DeZelar has handled 7 trademark applications.
What is James M. DeZelar's trademark registration success rate?
James M. DeZelar has a 0% trademark registration rate, with 0 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.